PT77230B - Broad spectrum influenza antisera - Google Patents

Broad spectrum influenza antisera

Info

Publication number
PT77230B
PT77230B PT77230A PT7723083A PT77230B PT 77230 B PT77230 B PT 77230B PT 77230 A PT77230 A PT 77230A PT 7723083 A PT7723083 A PT 7723083A PT 77230 B PT77230 B PT 77230B
Authority
PT
Portugal
Prior art keywords
antisera
broad spectrum
spectrum influenza
influenza
broad
Prior art date
Application number
PT77230A
Other languages
Portuguese (pt)
Other versions
PT77230A (en
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of PT77230A publication Critical patent/PT77230A/en
Publication of PT77230B publication Critical patent/PT77230B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT77230A 1982-08-23 1983-08-22 Broad spectrum influenza antisera PT77230B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41045582A 1982-08-23 1982-08-23

Publications (2)

Publication Number Publication Date
PT77230A PT77230A (en) 1983-09-01
PT77230B true PT77230B (en) 1986-02-04

Family

ID=23624803

Family Applications (1)

Application Number Title Priority Date Filing Date
PT77230A PT77230B (en) 1982-08-23 1983-08-22 Broad spectrum influenza antisera

Country Status (16)

Country Link
EP (1) EP0116629A4 (en)
JP (1) JPS59501714A (en)
KR (1) KR840006198A (en)
AU (1) AU570929B2 (en)
DK (1) DK203684A (en)
ES (1) ES8505819A1 (en)
FI (1) FI841583A0 (en)
GR (1) GR78931B (en)
IL (1) IL69556A (en)
IT (1) IT1168636B (en)
NO (1) NO161002C (en)
NZ (2) NZ205341A (en)
PH (1) PH18872A (en)
PT (1) PT77230B (en)
WO (1) WO1984000687A1 (en)
ZA (1) ZA836080B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241713A1 (en) * 1984-08-30 1992-11-30 Smithkline Beckman Corp Vaccinal polypeptides
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
WO1990008161A1 (en) * 1989-01-12 1990-07-26 The Blood Center Of Southeastern Wisconsin Peptide-mediated modulation of t-cell recognition as a means of affecting immune responses
EP0621339B1 (en) * 1992-09-17 2001-10-24 Takara Shuzo Co. Ltd. Immunogenic human influenza A virus haemagglutinin polypeptides
JP2996864B2 (en) * 1994-03-30 2000-01-11 寳酒造株式会社 Antibody variable region DNA
CA2652452C (en) * 2006-05-15 2018-07-31 Sea Lane Biotechnologies, Llc Neutralizing antibodies to influenza viruses
US8148085B2 (en) 2006-05-15 2012-04-03 Sea Lane Biotechnologies, Llc Donor specific antibody libraries
MX2009002174A (en) * 2006-09-07 2009-03-12 Crucell Holland Bv Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof.
ITTO20070066A1 (en) 2007-01-30 2008-07-31 Pomona Biotechnologies Llc ANTI-IDIOTYPE MONOCLONAL ANTIBODIES MIMOTOPI ANTIGENE GP 120 DI HIV
BRPI0809435A2 (en) 2007-03-27 2014-09-09 Sea Lane Biotechnologies Llc CONSTRUCTS AND LIBRARIES UNDERSTANDING ANTIBODY SUBSTITUTED LIGHT CHAIN SEQUENCES
ITTO20080204A1 (en) 2008-03-17 2009-09-18 Pomona Biotechnologies Llc MONOCLONAL ANTIBODIES ACTIONS TO REACT WITH A PLURALITY OF SUBTIPS OF THE INFLUENTIAL VIRUS A
AU2009228058A1 (en) 2008-03-28 2009-10-01 Sea Lane Biotechnologies, Llc Neutralizing molecules to viral antigens
ITTO20080398A1 (en) 2008-05-27 2009-11-28 Pomona Biotechnologies Llc MONOCLONAL ANTIBODIES HAVING PROPERTY OF HOSUBLICTIC CROSS-NEUTRALIZATION FOR INFLUENTIAL VIRUSES OF SUBTIPLE TYPE H1
ITTO20080964A1 (en) 2008-12-22 2010-06-23 Natimab Therapeutics S R L ANTI-HCV MONOCLONAL ANTIBODY AS A MEDICATION FOR THERAPEUTIC TREATMENT AND THE PREVENTION OF HCV INFECTIONS
EP2380976A4 (en) 2008-12-25 2012-11-07 Univ Osaka Human anti-human influenza virus antibody
EP3009145A1 (en) 2009-03-30 2016-04-20 Mount Sinai School of Medicine of New York University Influenza virus vaccines and uses thereof
EP2430047B1 (en) * 2009-05-13 2018-03-28 i2 Pharmaceuticals, Inc. Neutralizing molecules to influenza viruses
CA2800182A1 (en) 2009-05-26 2010-12-02 Mount Sinai School Of Medicine Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
IT1395961B1 (en) 2009-06-01 2012-11-02 Pomona Biotechnologies Llc MONOCLONAL ANTIBODIES AS A MEDICATION FOR THERAPEUTIC AND / OR PROFILACTIC TREATMENT OF INFLUENCIAL VIRUS INFECTIONS (H1N1) OF SWINE ORIGIN (S-OIV)
US9701723B2 (en) * 2010-02-18 2017-07-11 Icahn School Of Medicine At Mount Sinai Vaccines for use in the prophylaxis and treatment of influenza virus disease
CN102939103A (en) 2010-03-30 2013-02-20 西奈山医学院 Influenza virus vaccines and uses thereof
EP2736928B1 (en) 2011-07-28 2019-01-09 i2 Pharmaceuticals, Inc. Sur-binding proteins against erbb3
EP2758075B1 (en) 2011-09-20 2023-05-03 Icahn School of Medicine at Mount Sinai Influenza virus vaccines and uses thereof
WO2013096828A1 (en) 2011-12-22 2013-06-27 Sea Lane Biotechnologies, Llc Surrogate binding proteins
US9969794B2 (en) 2012-05-10 2018-05-15 Visterra, Inc. HA binding agents
AU2013362935B2 (en) 2012-12-18 2018-10-04 Icahn School Of Medicine At Mount Sinai Influenza virus vaccines and uses thereof
WO2014159960A1 (en) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
JP2018504412A (en) 2015-01-23 2018-02-15 アイカーン スクール オブ メディシン アット マウント サイナイ Influenza virus vaccination regimen
US10513553B2 (en) 2015-11-13 2019-12-24 Visterra, Inc. Compositions and methods for treating and preventing influenza
CA3023143A1 (en) 2016-06-15 2017-12-21 Icahn School Of Medicine At Mount Sinai Influenza virus hemagglutinin proteins and uses thereof
CA3058652A1 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
JP2022521819A (en) 2019-03-25 2022-04-12 ビステラ， インコーポレイテッド Compositions and Methods for Treating and Preventing Influenza

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI83662C (en) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostic antibody and procedure for its preparation

Also Published As

Publication number Publication date
PH18872A (en) 1985-10-21
AU1947183A (en) 1984-03-07
IT1168636B (en) 1987-05-20
JPS59501714A (en) 1984-10-11
DK203684D0 (en) 1984-04-18
GR78931B (en) 1984-10-02
WO1984000687A1 (en) 1984-03-01
FI841583A (en) 1984-04-19
NO161002C (en) 1989-06-21
EP0116629A4 (en) 1987-06-29
NO841540L (en) 1984-04-17
IL69556A (en) 1988-05-31
IL69556A0 (en) 1983-11-30
IT8348868A0 (en) 1983-08-22
NZ205341A (en) 1988-07-28
PT77230A (en) 1983-09-01
DK203684A (en) 1984-04-18
ZA836080B (en) 1984-04-25
NZ220612A (en) 1988-07-28
EP0116629A1 (en) 1984-08-29
AU570929B2 (en) 1988-03-31
KR840006198A (en) 1984-11-22
ES525088A0 (en) 1985-06-16
NO161002B (en) 1989-03-13
ES8505819A1 (en) 1985-06-16
FI841583A0 (en) 1984-04-19

Similar Documents

Publication Publication Date Title
IL69556A0 (en) Broad spectrum influenza antisera
JPS57109376A (en) High power mosfet
JPS56141069A (en) Generator
GB8529829D0 (en) Backsurging well
GB8316310D0 (en) Turbine
GB8324054D0 (en) Rotors
JPS5787598A (en) High performance
DE3167814D1 (en) Oil-cooled generator
JPS56150959A (en) Generator
GB2118237B (en) Ladder
GB2086759B (en) Tower packing elements
GB2089679B (en) Tower packing elements
JPS5787795A (en) Rotor plane
GB8308327D0 (en) Generator
CS108283A2 (en) Rizeni kloubu ctyrnapravovych kolejovych vozidel, zejmena vozu mestske dopravy
JPS5786047A (en) Peak spectrum generator/processor
GB8318694D0 (en) Ladder
JPS578301A (en) Rotary turbine
JPS5787796A (en) Rotor plane
GB2076691B (en) Impact-mill rotor
JPS56150960A (en) Generator
GB2368215B (en) Ranging
BG31627A1 (en) Power amplifyier
PHUM5259Z (en) Improved windmill
CS434982A1 (en) Spradaci rotor bezvretenove spradaci jednotky